Trintellix and Mirapex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trintellix (vortioxetine hydrobromide) and Mirapex (pramipexole dihydrochloride). Common drug interactions include emergency care among females and back disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Trintellix and Mirapex. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Trintellix?

Trintellix has active ingredients of vortioxetine hydrobromide. It is often used in depression. eHealthMe is studying from 13,067 Trintellix users. Check the latest studies of Trintellix.

What is Mirapex?

Mirapex has active ingredients of pramipexole dihydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 20,622 Mirapex users. Check the latest studies of Mirapex.



On Jul, 18, 2026

67 people who take Trintellix and Mirapex together, and have interactions are studied.

Trintellix and Mirapex drug interactions.

What are the common drug interactions of Trintellix and Mirapex, by gender? *:

female:

  1. Emergency care
  2. Feeling jittery
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Hepatic adenoma (benign liver tumour)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Incontinence (lack of moderation or self-control)
  7. Injection site erythema (redness at injection site)
  8. Injection site urticaria (rash of round, red welts on the skin at injection site)
  9. Pain
  10. Memory impairment

male:

  1. Back disorder
  2. Rash
  3. Drug hypersensitivity
  4. Drug ineffective
  5. Fall
  6. Fatigue (feeling of tiredness)
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  8. Irritable bowel syndrome
  9. Memory impairment
  10. Obesity (having too much body fat)

What are the common drug interactions of Trintellix and Mirapex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Drug ineffective
  2. Disease recurrence

40-49:

  1. Hospitalisation
  2. Gallbladder operation
  3. Diplopia (double vision)
  4. Pain
  5. Poor quality sleep
  6. Retinal vascular disorder (a range of eye diseases that affect the blood vessels in the eye)
  7. Cystitis (inflammation of the wall of the bladder)
  8. Memory impairment
  9. Spinal fusion surgery
  10. Hysterectomy

50-59:

  1. Abdominal pain
  2. Anaemia (lack of blood)
  3. Anxiety
  4. Back disorder
  5. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  6. Carditis (infection of heart and surrounding)
  7. Chest pain
  8. Fibromyalgia (a long-term condition which causes pain all over the body)
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Insomnia (sleeplessness)

60+:

  1. Pain in extremity
  2. Abdominal discomfort
  3. Haematemesis (vomiting of blood)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Infusion related reaction
  6. Platelet count decreased
  7. Pneumonia
  8. Psychotic disorder
  9. Respiratory tract infection
  10. Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 30 people, 44.78%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 16 people, 23.88%
  3. Immunodeficiency: 9 people, 13.43%
  4. Drowsiness: 6 people, 8.96%
  5. Insomnia (sleeplessness): 5 people, 7.46%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 5.97%

* Approximation only. Some reports may have incomplete information.

Do you take Trintellix and Mirapex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Trintellix and Mirapex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trintellix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mirapex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trintellix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mirapex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on vortioxetine hydrobromide and pramipexole dihydrochloride (the active ingredients of Trintellix and Mirapex, respectively), and Trintellix and Mirapex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: